⟵ Back to Search Results
BGB-dinutuximab beta-101

Not yet recruiting

Evaluation of the Safety and Pharmacokinetics of Dinutuximab Beta as Maintenance Therapy in Chinese Patients With High-risk Neuroblastoma

Beigene Study ID info

BGB-dinutuximab beta-101

ClinicalTrials.gov ID info

NCT05373901

Study Overview

Sex: All

Age: 12 Months and older   (Child, Adult, Older Adult)

No Study Documents

Locations

Study Overview

Sex: All

Age: 12 Months and older   (Child, Adult, Older Adult)

No Study Documents